Premium
The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997–2002)
Author(s) -
Falconer AD,
Hirschowitz L,
Weeks J,
Murdoch J
Publication year - 2007
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2006.01181.x
Subject(s) - medicine , audit , cohort , lymphadenectomy , cancer , skin cancer , surgery , general surgery , family medicine , management , economics
Objective The objective of this study was to assess the impact of reorganisation of gynaecological services in southwest England following adoption of regionally agreed evidence‐based guidelines and publication of the National Improving Outcomes Guidance in 1999. Design Prospective audit with cross‐checking against histological reports. Setting All 19 acute hospitals in the four Cancer Networks of southwest England. Sample All subjects with squamous or verrucous vulval cancer diagnosed between 1997 and 2002. Method A one‐page minimum data set proforma agreed by the South West Gynaecology Tumour Panel was completed by surgeons after treatment of each patient, and was sent to South West Cancer Intelligence Service for entry, collation and analysis. Data are presented for the years 1997 to 2002 inclusive, and comparisons were made between each of the three 2‐year cohorts. Main outcome measures These are standards derived from the guidance. Results There were 436 squamous or verrucous vulval cancers registered. Recording of staging was missing in 20% of subjects. The percentage of subjects operated upon by lead gynaecological cancer surgeons increased from 78% in cohort 1 to 93% in cohort 3 ( P < 0.001). There is a trend towards more conservative operations, which have lower co‐morbidity. High activity surgeons achieved better rates of tumour‐free skin margins, but even these were adequate only in 49% of operations. Lymphadenectomy rates did not follow guidance. Conclusion Centralisation of care of this rare cancer should continue, but specialists need to increase their efforts to ensure adequate skin margins and lymphadenectomy rates while balancing morbidity and the likelihood of recurrence in both fit and frail patients.